130 related articles for article (PubMed ID: 9522439)
21. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
22. Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase.
Satoh T; Fujita KI; Munakata H; Itoh S; Nakamura K; Kamataki T; Itoh S; Yoshizawa I
Anal Biochem; 2000 Nov; 286(2):179-86. PubMed ID: 11067738
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
[TBL] [Abstract][Full Text] [Related]
24. Expression of house fly CYP6A1 and NADPH-cytochrome P450 reductase in Escherichia coli and reconstitution of an insecticide-metabolizing P450 system.
Andersen JF; Utermohlen JG; Feyereisen R
Biochemistry; 1994 Mar; 33(8):2171-7. PubMed ID: 8117673
[TBL] [Abstract][Full Text] [Related]
25. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein.
Wang MH; Stec DE; Balazy M; Mastyugin V; Yang CS; Roman RJ; Schwartzman ML
Arch Biochem Biophys; 1996 Dec; 336(2):240-50. PubMed ID: 8954571
[TBL] [Abstract][Full Text] [Related]
26. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
[TBL] [Abstract][Full Text] [Related]
27. Baculovirus-mediated expression and functional characterization of human NADPH-P450 oxidoreductase.
Tamura S; Korzekwa KR; Kimura S; Gelboin HV; Gonzalez FJ
Arch Biochem Biophys; 1992 Mar; 293(2):219-23. PubMed ID: 1536559
[TBL] [Abstract][Full Text] [Related]
28. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
29. Creation of polarized cells coexpressing CYP3A4, NADPH cytochrome P450 reductase and MDR1/P-glycoprotein.
Brimer C; Dalton JT; Zhu Z; Schuetz J; Yasuda K; Vanin E; Relling MV; Lu Y; Schuetz EG
Pharm Res; 2000 Jul; 17(7):803-10. PubMed ID: 10990198
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli.
Blake JA; Pritchard M; Ding S; Smith GC; Burchell B; Wolf CR; Friedberg T
FEBS Lett; 1996 Nov; 397(2-3):210-4. PubMed ID: 8955349
[TBL] [Abstract][Full Text] [Related]
31. Optimization of heme precursors for the expression of human cytochrome P450 2A13 and its co-expression with oxidoreductase in baculovirus/sf9 system.
Lu HY; Qiu LL; Yang XJ; Zhang XM; Zhang Z; Wang SL
J Biochem; 2013 Jun; 153(6):555-63. PubMed ID: 23463547
[TBL] [Abstract][Full Text] [Related]
32. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
33. Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9.
Jean P; Lopez-Garcia P; Dansette P; Mansuy D; Goldstein JL
Eur J Biochem; 1996 Nov; 241(3):797-804. PubMed ID: 8944768
[TBL] [Abstract][Full Text] [Related]
34. Cloning and heterologous expression of NADPH-cytochrome P450 reductases from the Papaveraceae.
Rosco A; Pauli HH; Priesner W; Kutchan TM
Arch Biochem Biophys; 1997 Dec; 348(2):369-77. PubMed ID: 9434750
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
36. Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli.
Pritchard MP; Glancey MJ; Blake JA; Gilham DE; Burchell B; Wolf CR; Friedberg T
Pharmacogenetics; 1998 Feb; 8(1):33-42. PubMed ID: 9511179
[TBL] [Abstract][Full Text] [Related]
37. Phosphonate O-deethylation of [4-(4-bromo-2-cyano-phenylcarbamoyl) benzyl]-phosphonic acid diethyl ester, a lipoprotein lipase-promoting agent, catalyzed by cytochrome P450 2C8 and 3A4 in human liver microsomes.
Morioka Y; Otsu M; Naito S; Imai T
Drug Metab Dispos; 2002 Mar; 30(3):301-6. PubMed ID: 11854149
[TBL] [Abstract][Full Text] [Related]
38. Functional properties of a rainbow trout CYP3A27 expressed by recombinant baculovirus in insect cells.
Lee SJ; Buhler DR
Drug Metab Dispos; 2002 Dec; 30(12):1406-12. PubMed ID: 12433811
[TBL] [Abstract][Full Text] [Related]
39. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
[TBL] [Abstract][Full Text] [Related]
40. Genotoxic activation of benzophenone and its two metabolites by human cytochrome P450s in SOS/umu assay.
Takemoto K; Yamazaki H; Nakajima M; Yokoi T
Mutat Res; 2002 Aug; 519(1-2):199-204. PubMed ID: 12160905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]